In vivo antiviral effects of mismatched double-stranded RNA on duck hepatitis B virus

J Med Virol. 1994 Jun;43(2):161-5. doi: 10.1002/jmv.1890430212.

Abstract

The antiviral activity and ability of mismatched double-stranded RNA (m-dsRNA), r(I)n.r(C12-U)n, to induce interferon (IFN) were evaluated in ducks chronically infected with duck hepatitis B virus (DHBV). When m-dsRNA was administered intravenously at a single dose of 5 mg/kg, serum DHBV DNA concentrations decreased significantly for 3 days (P < 0.002). However, the DHBV DNA concentrations returned to the pretreatment levels 4 days after treatment. Inhibition of DHBV DNA replication in the liver was also observed 2 days after treatment. Serum IFN activity peaked 3 hours after administration of m-dsRNA, then rapidly declined. 2'-5' Oligo-adenylate synthetase (2'-5'AS) activity increased gradually after treatment and remained elevated for at least 48 hours. In ducks receiving m-dsRNA once daily for 7 consecutive days, serum DHBV DNA concentrations on the last day of treatment were decreased by 76 +/- 12% (P < 0.05) in ducks that received 0.2 mg of m-dsRNA per kg and by 65 +/- 12% (P < 0.05) in ducks that received 1 mg of m-dsRNA per kg. This decrease persisted for at least 2 weeks after the cessation of treatment in all ducks. These results suggest that m-dsRNA effectively inhibits DHBV replication in vivo, and that IFN induction and stimulation of 2'-5'AS activity contribute to the inhibition of DHBV replication by m-dsRNA.

MeSH terms

  • Animals
  • Antiviral Agents / administration & dosage*
  • DNA, Viral / blood
  • DNA, Viral / drug effects
  • Drug Administration Schedule
  • Ducks
  • Hepadnaviridae Infections / blood
  • Hepadnaviridae Infections / therapy*
  • Hepatitis B Virus, Duck / drug effects
  • Hepatitis B Virus, Duck / physiology*
  • Injections, Intravenous
  • Interferon-alpha / blood
  • Liver / drug effects
  • Liver / microbiology
  • Poly I-C / administration & dosage*
  • Poly U / administration & dosage*
  • RNA, Double-Stranded / administration & dosage*
  • Time Factors
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • DNA, Viral
  • Interferon-alpha
  • RNA, Double-Stranded
  • Poly U
  • poly(I).poly(c12,U)
  • Poly I-C